PGIM Jennison Health Sciences Fund - Class A (PHLAX)

NASDAQ · Mutual Fund · Delayed Price · Currency is USD
33.31
-0.25 (-0.74%)
Mar 13, 2026, 9:30 AM EST
Fund Assets1.46B
Expense Ratio1.13%
Min. Investment$1,000
Turnover81.00%
Dividend (ttm)5.05
Dividend Yield14.32%
Dividend Growth-5.01%
Payout FrequencyAnnual
Ex-Dividend DateDec 19, 2025
Previous Close33.56
YTD Return-6.04%
1-Year Return13.95%
5-Year Return45.69%
52-Week Low29.55
52-Week High41.48
Beta (5Y)n/a
Holdings52
Inception DateJun 30, 1999

About PHLAX

PGIM Jennison Health Sciences Fund Class A is a mutual fund focused on long-term capital appreciation by investing primarily in equity and equity-related securities of U.S. companies within the healthcare sector. The fund targets firms engaged in pharmaceuticals, biotechnology, medical equipment, hospitals, nursing care, and health insurance carriers. With assets totaling approximately $1.68 billion and an expense ratio of about 1.13%, it offers exposure to a diversified portfolio of around 46 holdings, including prominent healthcare companies such as Eli Lilly, UnitedHealth Group, and Bristol-Myers Squibb. Since its inception in 1999, the fund has sought to leverage healthcare innovation and growth trends to deliver value, making it a specialized vehicle within the health sciences investment space. The fund pays dividends annually and maintains a focus on large growth companies in the health sector.

Fund Family PGIM
Category Health
Performance Rating Above Average
Risk Rating Average
Stock Exchange NASDAQ
Ticker Symbol PHLAX
Share Class Class A
Index S&P Composite 1500 Health Care TR

Performance

PHLAX had a total return of 13.95% in the past year, including dividends. Since the fund's inception, the average annual return has been 13.99%.

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

SymbolShare ClassExpense Ratio
PHLQXClass R60.77%
PHSZXClass Z0.86%
PJHRXClass R1.48%
PHLCXClass C1.96%

Top 10 Holdings

57.26% of assets
NameSymbolWeight
Eli Lilly and CompanyLLY16.73%
Thermo Fisher Scientific Inc.TMO5.70%
Merck & Co., Inc.MRK5.42%
Danaher CorporationDHR5.22%
Prudential Govt Money Mkt Fdn/a5.05%
Gilead Sciences, Inc.GILD4.96%
UnitedHealth Group IncorporatedUNH4.26%
argenx SEARGX3.44%
Vertex Pharmaceuticals IncorporatedVRTX3.40%
CVS Health CorporationCVS3.09%
View More Holdings

Dividend History

Ex-DividendAmountPay Date
Dec 19, 2025$5.04682Dec 19, 2025
Dec 20, 2024$5.31325Dec 20, 2024
Dec 20, 2023$1.91322Dec 20, 2023
Dec 20, 2022$0.61624Dec 20, 2022
Dec 20, 2021$14.02528Dec 20, 2021
Dec 20, 2019$1.43164Dec 20, 2019
Full Dividend History